Non-timely referral of women aged 40 to 69 to preventive medicine for breast cancer detection and its association with the BI-RADS classification.

BI-RADS classification Family medicine Family physician Hospital referral Mammography Preventive medicine

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 11 01 2023
revised: 01 08 2023
accepted: 13 08 2023
medline: 1 9 2023
pubmed: 1 9 2023
entrez: 1 9 2023
Statut: epublish

Résumé

In the first level of health care, the timely detection of breast cancer is essential to prevent the progression of the disease, obtain optimal treatment and improve the prognosis and survival of patients. The objective of this study was to analyze the opportunity in referral to the Preventive Medicine Modules offered to women aged 40 to 69 years of the Family Medicine Unit 1, of the Mexican Social Security Institute, Decentralized Administrative Operation Body, Aguascalientes, Mexico, by their family physician, and its impact in the findings of mammographic screening according to the BI-RADS classification. Methods This was a cross-sectional comparative study of 412 mammograms performed on women aged 40 to 69, who were treated in the preventive medicine modules from January 2019 to June 2021. Data collection was carried out by simple random sampling using a checklist. Multiple logistic regression models adjusted for age were applied. A total of 90.29% of the patients who underwent screening mammography were not referred in a timely manner to the preventive medicine modules by the family physician, this delay in diagnosis and treatment increased by 3.01 times the probability of having a classification BI-RADS suspected of malignancy compared to those women whose referral was timely (OR adj = 3.01, 95% CI 1.04-8.72, p = 0.041). The untimely referral of women aged 40-69 to preventive medicine modules for the detection of breast cancer increases the risk of finding a malignant lesión.

Identifiants

pubmed: 37654516
doi: 10.1016/j.pmedr.2023.102369
pii: S2211-3355(23)00260-7
pmc: PMC10465932
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102369

Informations de copyright

© 2023 Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Prev Med. 1999 Nov;29(5):391-404
pubmed: 10564631
Gac Med Mex. 2018;154(6):665-670
pubmed: 30532095
Cir Cir. 2004 Nov-Dec;72(6):503-10
pubmed: 15694059
J Anim Ecol. 2006 Sep;75(5):1182-9
pubmed: 16922854
Cancer. 2020 May 15;126 Suppl 10:2469-2480
pubmed: 32348563
Can Fam Physician. 2012 Jan;58(1):e47-53
pubmed: 22267639
Asian Pac J Cancer Prev. 2020 Feb 01;21(2):317-324
pubmed: 32102505
Salud Publica Mex. 2009;51 Suppl 2:s263-9
pubmed: 19967282
Ned Tijdschr Geneeskd. 2015;159:A8636
pubmed: 25804111
Eur J Gen Pract. 2020 Dec;26(1):95-101
pubmed: 32674614
Medscape Womens Health. 2001 Oct;6(5):6
pubmed: 11698928
BMC Public Health. 2019 Jun 26;19(1):823
pubmed: 31242882

Auteurs

Georgina Lizeth Villagrana Gutiérrez (GLV)

Headship Family Medicine, FMU1, DAOB Aguascalientes, IMSS, ZC 20270 Aguascalientes, México.

Alberto Monroy García (AM)

Immunology and Cancer Laboratory, UIMEO, H Oncology, CMN SXXI, IMSS, Z.C. 06720 México City, México.
Immunobiology Laboratory, UIDCC-UMIEZ, FES-Zaragoza, UNAM, Z.C 09230 México City, México.

Evelyn Patricia Larraga Benavente (EPL)

Clinical Coordination of Education and Research, FMU1, DAOB Aguascalientes, IMSS, Z.C. 20270 Aguascalientes, México.

Fernando Herrera Mejía (FH)

Epidemiology Service, FMU1, DAOB Aguascalientes, IMSS, Z.C. 20270 Aguascalientes, México.

Roberto Terrones Gómez (RT)

Medical Direction, FMU1, DAOB Aguascalientes, IMSS, Z.C 20270 Aguascalientes, México.

Fernando Rodríguez Villalón (FR)

General Hospital of Zone 1, DAOB Aguascalientes, IMSS, Z.C. 20270 Aguascalientes, México.

Classifications MeSH